Submitted Successfully!
Thank you for your contribution! You can also upload a video entry related to this topic through the link below:
Check Note
Ver. Summary Created by Modification Content Size Created at Operation
1 + 2284 word(s) 2284 2021-07-13 07:56:47 |
2 format correct + 272 word(s) 2556 2021-07-13 09:57:19 |
Diagnosis of Early Gastrointestinal Neoplasia
Upload a video

Meticulous endoscopic characterization of gastrointestinal neoplasias (GN) is crucial to the clinical outcome. Hereby the indication and type of resection (endoscopically, en-bloc or piece-meal, or surgical resection) are determined. By means of established image-enhanced (IEE) and magnification endoscopy (ME) GN can be characterized in terms of malignancy and invasion depth. In this context, the statistical evidence and accuracy of these diagnostic procedures should be elucidated. Here, we present a systematic review of the literature. Results: 21 Studies could be found which met the inclusion criteria. In clinical prospective trials and meta-analyses, the diagnostic accuracy of >90% for characterization of malignant neoplasms could be documented, if ME with IEE was used in squamous cell esophageal cancer, stomach, or colonic GN. Conclusions: Currently, by means of optical diagnosis, today’s gastrointestinal endoscopy is capable of determining the histological subtype, exact lateral spread, and depth of invasion of a lesion. The prerequisites for this are an exact knowledge of the anatomical structures, the endoscopic classifications based on them, and a systematic learning process, which can be supported by training courses. More prospective clinical studies are required, especially in the field of Barrett’s esophagus and duodenal neoplasia.

  • endoscopy
  • neoplasia
  • magnification endoscopy
  • chromoendoscopy
  • invasion depth
Contributor :
View Times: 52
Revisions: 2 times (View History)
Update Time: 13 Jul 2021

1. Introduction

Gastrointestinal carcinomas have the highest incidence (19.2% of all new cancer cases) and mortality worldwide (23% of annual worldwide cancer mortality, 1.81 million [1]). As a result of an increase in endoscopic (screening) examinations and the continuous improvement of the optical quality of endoscopic equipment, T1 carcinomas in the gastrointestinal tract (GIT) are increasingly detected and diagnosed. e.g., 7–17% of colonic T1 carcinomas already have LM [2], which significantly depends on the depth of invasion. This number was significantly lower (11%) in the group of correctly characterized T1 carcinomas.

However, with aids such as attachment caps, underwater magnification and digital zoom, magnifications of up to 75-fold can be achieved with conventional HD endoscopes. Complemented by contrast-enhanced endoscopy (image-enhanced endoscopy, IEE) based on staining (true chromoendoscopy, CE) or device-based, virtual chromoendoscopy (e.g., as narrow-band imaging, NBI or blue light imaging, BLI), the accuracy of endoscopic characterization of lesions in the GIT could be improved dramatically. Device-based IEE, such as NBI, enables improved contrasting of vascular structures by emission of blue and green light of a defined wavelength (in the absorption range of hemoglobin). Based on changes in the microsurface structure (SP) and the microvascular pattern (capillary structures, VP), numerous classifications of pathological changes have been published in the various areas of the GIT in recent years, the most important of which will be presented and evaluated in terms of evidence and practical application in this review.

2. Examination Procedure, Detection and Characterization

A high quality of the endoscopic examination (e.g., good bowel preparation, mucolytic/surface preparation of the mucosa, meticulous examination technique, standardized examination protocols) is the prerequisite for reliable detection and characterization of suspicious lesions Already in the first step, on the basis of morphology and certain additional features (e.g., sharp delineation, inhomogeneity of color distribution), reliable conclusions about the endoscopic resectability of the lesion can often be made, not requiring ME (NICE classification in the colon and rectum [3][4], GUP system in the stomach [5]). Thus, more than 50% of LST (lateral spreading tumors) of the non-granular type in the colon and up to 80% of all flat (0-II) lesions in the stomach are associated with malignant histology [6][7]. To further characterize gastrointestinal neoplasms (dignity, lateral extent, and depth of invasion), VP and (ideally with CE)

2.1. Esophagus

In the squamous esophagus, sessile/polypoid (0-Is/p) or ulcerative neoplasms (0-III) have the highest risk of deep submucosal invasion (SMI, >80%). However, even shallow lesions (0-II) already have a risk of SMI of 15–53% [37]. Similarly, in Barrett’s esophagus, up to 45% of 0-IIa lesions already represent T1b carcinomas [38]. Therefore, a closer characterization at the micro-level by combining ME and IEE is required. Only two studies in the context of squamous cell carcinoma (SCC) met the inclusion criteria (Table 1). The recently published JES classification of the Japanese Esophageal Society, which is a further development of the IPCL classification [39], showed a statistical accuracy of 91% regarding the depth of invasion in a prospective study [15]. This was also confirmed in a recent meta-analysis [14]. This classification is based on the pattern of microvessels (VP) and their degree of dilatation. Four VP types are defined, which allows for a subtle assessment of the degree of submucosal invasion of SCC in the esophagus. Only intramucosal SCC is appropriate for endoscopic resection (JES type B1). Lesions invading the muscularis mucosae or the upper layer of the submucosa (JES type B2) are a relative contraindication for endoscopic resection.

Table 1. Studies obtained by the systematic literature search on optical diagnosis of gastrointestinal neoplasia.
Imaging Technique Study Type n st. n Lesions Accuracy (%) Sensitivity (%) Specificy (%) First Author Year Ref.
Esophagus, squamous cell carcinoma, T1a vs. T1b
ME-NBI vs. WLE, JES Meta-A. 10 1033   90 90 Yu 2018 [8]
ME-NBI, JES Prosp.   200 91     Oyama 2017 [9]
Barrett’s esophagus, high grade dysplasia/early adenocarcinoma
NBI, BING Prosp.   120 85 91 93 Sharma 2016 [10]
ME-NBI, simplif. Prosp.   248 95     Kato 2017 [11]
Stomach, early gastric cancer
NBI vs. WLE, simplif. Prosp.   238 94 92   Pimentel-Nunes 2012 [12]
ME-NBI vs. WLE, SD Meta-A. 10 2151   87 a 93 vs. 65 Lv 2015 [13]
ME-NBI Meta-A. 9 5398   88 96 Zhou 2018 [14]
ME-NBI vs. WLE, SD Rand., Prosp.   40 97 95 97 Ezoe 2011 [15]
ME-NBI vs. WLE, SD Meta-A. 10 2153 96 83 96 Zhang 2015 [16]
ME-NBI vs. WLE, SD Meta-A. 14 2171   86 96 Hu 2015 [17]
ME-NBI, VS Rand., Prosp.   1097 98 86 99 Yao 2014 [18]
ME-NBI, VS Syst. Rev. 66   95 PPV 79 NPV 99 Muto 2016 [19]
Colorectum, early CRC
ME(-NBI) vs. WLE b Meta-A. 13     80 b   Parikh 2016 [20]
ME-NBI vs. ME-CE e Meta-A. 17   97 84 c 97 c Zhang 2017 [21]
ME d Meta-A. 20 5111 94 89 96 Li 2014 [22]
ME-NBI, JNET Prosp.   40 90     Minoda 2019 [23]
ME-NBI, JNET Prosp.   2933 97 55 100 Sumimoto 2017 [24]
NBI, NICE Prosp.   2123   58 96 Puig 2018 [25]
SP and/or VP d Meta-A. 36 9607 99 f     Guo 2018 [26]
ME-NBI, -CE vs. WLE e Meta-A. 33 31,568   90   Backes 2017 [27]
NBI and WLE e Prosp.   343   79   Backes 2019 [28]
Abbreviations: st.: studies, Ref.: reference, ME: magnification endoscopy, NBI: narrow band imaging, WLE: white light endoscopy, JES: classification of the Japan esophageal society, Meta-A.: Meta-Analysis, prosp.: prospective, BING: Barrett’s International NBI Group, simplif.: simplified NBI classification, SD: standard definition, Rand.: randomized, prosp.: prospective, VS: vessel plus surface-classification, Syst. Rev.: systematic review, PPV: positive predictive value, NPV: negative predictive value, CRC: colorectal cancer, CE: chromoendoscopy, JNET: Japan NBI expert team classification, NICE: narrow-band imaging international colorectal endoscopic classification, SP: surface pattern, VP: vascular pattern. a vs. 61%, WLE; b ME-NBI, 60% f. NBI, sessile serrated adenoma vs. Adenoma vs. hyperplastic polyp; c ME-CE, invasive CRC; d neoplastic lesion; e invasive CRC; f SP and VP combined.

Also in Barrett’s esophagus, ME-NBI (for VP) and acetic acid-based ME-CE (for SP) can identify areas of high-grade intraepithelial neoplasia or early carcinoma with more than 90% sensitivity and specificity, and low interobserver variability [10][11][29][30]. Only two studies in the context of Barrett’s carcinoma met the inclusion criteria (BING classification validation study and simplified NBI classification, Table 1). The most recent of the existing classifications of Barrett’s esophagus is the JES-BE classification, which applies the clinically well-studied criteria in gastric carcinoma to the changes in Barrett’s carcinoma [42]. In brief, similarly to the BING classification, mucosal and vascular patterns are classified separately (regular or irregular). In the JES-BE classification, visibility and morphologic features (e.g., pit or network) are specified additionally. This classification reflects the natural highly variable appearance of Barrett’s lesions. Of note, this classification has not yet been validated in clinical prospective studies. However, quadrant biopsies according to the Seattle protocol cannot be dispensed, as about half of early malignant neoplasms are detected by “protocol biopsies” [31][32]. Assessment of depth of invasion is challenging in Barrett’s (early) carcinoma—in practice, a combined view of morphology and SP/VP is recommended. Deep SMI is very likely in all sessile (0-Is), elevated (0-IIa), sunken (0-IIc), or ulcerated (0-III) lesions in combination with a highly irregular VP (i.e., high variability of vessel diameters, low density) and/or amorphous or very irregular SP [35].

2.2. Stomach

In order to achieve the highest detection rates and accuracy of characterization, a combination of meticulous WLE followed by ME-NBI is currently recommended [44]. Already with WLE, a high quality of detection of suspicious lesions can be achieved after good preparation, taking into account the medical history (risk factors such as helicobacter pylori infection). Here, a standardized systematic screening protocol is recommended [45]. Localization, color, demarcability to the surrounding mucosa, and morphology should be analyzed for each suspicious lesion. However, beyond WLE, the ME-NBI technique which allows analysis of the specific anatomical structures (e.g., subepithelial capillaries and marginal crypt epithelium), especially in small gastritis-like lesions, is crucial for characterization. Eight studies and meta-analyses met the inclusion criteria (Table 1), showing a very high diagnostic accuracy (>95%) of ME-NBI in characterization in the context of early gastric cancer. Figures 3 and 4 illustrate this diagnostic process and the correlations with histologic criteria (differentiated early carcinoma in the antrum). The “vessel plus surface” classification enables differential diagnosis of differentiated early carcinoma (sharp demarcation in combination with irregular SP and/or VP) with a sensitivity and specificity of 95%, which was confirmed in a recently published meta-analysis [20]. In this classification, three categories exist for SP and VP, respectively: regular, irregular, and absent. The presence of an irregular VP with a demarcation line, or the presence of an irregular SP with a demarcation line is diagnostic for early gastric cancer. In this context, the “white zone” is equivalent to the gastric SP, anatomically correlated to the marginal crypt epithelium. In Figures 3 and 4, all features of the vessel plus surface classification are shown for a neoplastic lesion and normal mucosa with corresponding histopathological sections, respectively. Weaknesses exist in the diagnosis of undifferentiated gastric carcinomas (G3, G4), which may appear as pale, sunken lesions on WLE, and may often have poorly defined delineation and, in some circumstances, an inconspicuous SP (if diffusely subepithelial) on ME-NBI. The depth of invasion of differentiated carcinomas is reliably assessed by macroscopic morphology (Paris type, fold criteria), VP, and SP. Thus, a raised or sunken/ulcerated lesion with loss of SP has a >80% risk of massive SMI (≥SM2, [46]).

2.3. Colon

Nine prospective studies and meta-analyses met the inclusion criteria (Table 1), showing a very high diagnostic accuracy (>90%) of ME-NBI in characterization in the context of early colorectal cancer. To achieve >90% statistical confidence in the characterization of colorectal neoplasms it is essential to evaluate colorectal neoplasms according to VP (Sano or JNET, in ME-NBI) and SP (pit pattern according to Kudo, in ME-CE [32,47][32,46]). In Figure 5, two examples of endoscopic diagnosis (WLE, NBI, and CE) of colorectal lesions are demonstrated. Both lesions show a centrally sunken surface when examined by WLE alone (IIa + IIc). ME-NBI shows an irregular dense or highly irregular rarefied vascular pattern (VP) in the central area, respectively. Supplementary CE allows for the assessment of the VP (irregular, high density, or amorphous surface). JNET classification is based on this analysis algorithm to distinguish hyperplastic, adenomatous, superficial malignant, and deeply invasive lesions [48]. In brief, for each lesion VP and SP are evaluated separately. Variable caliber or irregular distribution of VP and/or irregular or obscure SP are diagnostic for high-grade intramucosal neoplasia or shallow submucosal cancer (JNET Type 2B). Loose vessel areas or interruption of thick vessels and/or amorphous SP are diagnostic for deep submucosal invasive cancer (JNET Type 3), not suitable for endoscopic resection. Morphological criteria such as nodular formations on polyps, amorphous color changes, bleeding tendency, and central ulceration with lack of surface structure, as well as fixed deformities after desufflation have high importance in terms of estimation of deep SMI (>1000µm) and endoscopic non-resectability. In this regard, analysis by ME-NBI supported by CE (crystal violet, indigo carmine) could show sensitivities of 84–90% and a pooled specificity of 98% in a recent meta-analysis (independent of the classification system used). This is significantly superior to a mere WLE diagnosis [27,33]. The NBI international colorectal endoscopic classification (NICE), which utilizes NBI without ME, allowed for a specificity of >96% in identifying invasive, i.e., endoscopically unresectable T1 colorectal tumors [31].

3. Discussion

Early carcinomas are increasingly detected in the gastrointestinal tract, with T1 carcinomas already showing lymph node metastases in up to 17%. Here, the depth of invasion is a major risk factor. The accuracy in the characterization of colorectal neoplasia using solely WLE in standard definition (SD) is 59% [33]. Endoscopic optical diagnostics with the aid of magnification endoscopy (ME), true (CE) and so-called virtual chromoendoscopy (e.g., NBI or BLI) can determine histology and depth of invasion with very high accuracy (>90%) and thus overcome the so-called sampling error or discordant results of a biopsy. Based on this assessment and supplemented by other imaging modalities (EUS, radiological diagnostics), an essential decision in the therapy of early carcinomas can thus be made: curative endoscopic resection, or surgical resection with lymph node dissection, respectively. Of note, also detection rates of adenomas in surveillance colonoscopy can be massively improved by advanced imaging techniques [34].
However, although the means of endoscopic visual diagnosis at the HD level allow very accurate characterization and are now widely available, the rate of mischaracterized early carcinomas in the GIT is alarmingly high. There are some weaknesses in the endoscopic diagnosis of colorectal lesions, and the characterization of colorectal lesions is of suboptimal quality [35]. In the prospective multicenter study by Vleugels, endoscopists correctly diagnosed T1 colorectal cancers in only 39% of 92 cases, which led to significant differences in treatment outcomes. Another prospective clinical trial comparing diagnostic accuracy in colorectal lesions > 10 mm using the NICE classification showed a sensitivity of 58% and a specificity of 96% to determine invasive colorectal tumors. The weakness of the NICE classification is the lack of a subcategory, identifying lesions with high-grade dysplasia or superficial submucosal invasive carcinomas, suitable for en-bloc endoscopic submucosal dissection. This may bear the risk of piece meal resection of early colorectal carcinomas. Of note, this undertreatment of malignant lesions by piece-meal resection led to the differences in the clinical outcome in the study by Vleugels [35]. The JNET classification, which utilizes ME-NBI, allows identifying such lesions (JNET category 2 B). However, the accuracy of identifying Type 2B-lesions was lower (75%) than those of other JNET categories [24]. Similarly, there are diagnostic limitations in the optical diagnosis of undifferentiated gastric adenocarcinoma and a missing demarcation line in cases after eradication of helicobacter pylori [36][37][38].
In experienced hands, endoscopic optical characterization of early gastrointestinal neoplasia has shown to be feasible and very helpful in clinical practice. However, the performance varies substantially among endoscopists, depending on their experience and a learning process that can be supported by seminars, e-learning, and new bioinformatical methods [39]. A recent initiative by the European Society of Gastrointestinal Endoscopy (ESGE) focuses on the criteria for optical diagnosis proficiency and training methods. Their position statement [40] defines the prerequisites for competency, proficiency, and competence thresholds in optical diagnosis. However, in a former guideline, ESGE suggests that routine use of advanced imaging for detection and differentiation of colorectal neoplasia in average-risk patients has to be balanced against costs and practical considerations [41].

4. Conclusions

Currently, by the means of optical diagnosis, today’s gastrointestinal endoscopy is capable to determine the histological subtype, exact lateral spread, and depth of invasion of a lesion, especially of the esophagus, stomach, and colon. Magnification and (virtual) chromoendoscopy, which have been increasingly available in the past years, have a statistical accuracy of more than 90%, which is essential to select the optimal oncological therapy strategy in early gastrointestinal neoplasia. The prerequisites for this are an exact knowledge of the anatomical structures, the endoscopic classifications based on them, and a systematic learning process, supported by training courses. Nevertheless, there is only limited data on the endoscopic characterization of duodenal neoplasms and in the field of Barrett’s esophagus in the literature. More prospective clinical studies are required.


  1. Ferlay, J.; Soerjomataram, I.; Dikshit, R.; Eser, S.; Mathers, C.; Rebelo, M.; Parkin, D.M.; Forman, D.; Bray, F. Cancer incidence and mortality worldwide: Sources, methods and major patterns in globocan 2012. Int. J. Cancer 2015, 136, E359–E386.
  2. Saitoh, Y.; Inaba, Y.; Sasaki, T.; Sugiyama, R.; Sukegawa, R.; Fujiya, M. Management of colorectal t1 carcinoma treated by endoscopic resection. Dig. Endosc. 2016, 28, 324–329.
  3. Hewett, D.G.; Kaltenbach, T.; Sano, Y.; Tanaka, S.; Saunders, B.P.; Ponchon, T.; Soetikno, R.; Rex, D.K. Validation of a simple classification system for endoscopic diagnosis of small colorectal polyps using narrow-band imaging. Gastroenterology 2012, 143, 599–607.E1.
  4. Hayashi, N.; Tanaka, S.; Hewett, D.G.; Kaltenbach, T.R.; Sano, Y.; Ponchon, T.; Saunders, B.P.; Rex, D.K.; Soetikno, R.M. Endoscopic prediction of deep submucosal invasive carcinoma: Validation of the narrow-band imaging international colorectal endoscopic (nice) classification. Gastrointest. Endosc. 2013, 78, 625–632.
  5. Yao, K.; Uedo, N.; Muto, M.; Ishikawa, H.; Cardona, H.J.; Filho, E.C.C.; Pittayanon, R.; Olano, C.; Yao, F.; Parra-Blanco, A.; et al. Development of an e-learning system for the endoscopic diagnosis of early gastric cancer: An international multicenter randomized controlled trial. EBioMedicine 2016, 9, 140–147.
  6. Uraoka, T.; Saito, Y.; Matsuda, T.; Ikehara, H.; Gotoda, T.; Saito, D.; Fujii, T. Endoscopic indications for endoscopic mucosal resection of laterally spreading tumours in the colorectum. Gut 2006, 55, 1592–1597.
  7. Rembacken, B.J.; Fujii, T.; Cairns, A.; Dixon, M.F.; Yoshida, S.; Chalmers, D.M.; Axon, A.T. Flat and depressed colonic neoplasms: A prospective study of 1000 colonoscopies in the uk. Lancet 2000, 355, 1211–1214.
  8. Yu, T.; Geng, J.; Song, W.; Jiang, Z. Diagnostic accuracy of magnifying endoscopy with narrow band imaging and its diagnostic value for invasion depth staging in esophageal squamous cell carcinoma: A systematic review and meta-analysis. BioMed Res. Int. 2018, 2018, 8591387.
  9. Oyama, T.; Inoue, H.; Arima, M.; Momma, K.; Omori, T.; Ishihara, R.; Hirasawa, D.; Takeuchi, M.; Tomori, A.; Goda, K. Prediction of the invasion depth of superficial squamous cell carcinoma based on microvessel morphology: Magnifying endoscopic classification of the japan esophageal society. Esophagus J. Jpn. Esophageal Soc. 2017, 14, 105–112.
  10. Sharma, P.; Bergman, J.J.; Goda, K.; Kato, M.; Messmann, H.; Alsop, B.R.; Gupta, N.; Vennalaganti, P.; Hall, M.; Konda, V.; et al. Development and validation of a classification system to identify high-grade dysplasia and esophageal adenocarcinoma in barrett’s esophagus using narrow-band imaging. Gastroenterology 2016, 150, 591–598.
  11. Kato, M.; Goda, K.; Shimizu, Y.; Dobashi, A.; Takahashi, M.; Ikegami, M.; Shimoda, T.; Kato, M.; Sharma, P. Image assessment of barrett’s esophagus using the simplified narrow band imaging classification. J. Gastroenterol. 2017, 52, 466–475.
  12. Pimentel-Nunes, P.; Libanio, D.; Lage, J.; Abrantes, D.; Coimbra, M.; Esposito, G.; Hormozdi, D.; Pepper, M.; Drasovean, S.; White, J.R.; et al. A multicenter prospective study of the real-time use of narrow-band imaging in the diagnosis of premalignant gastric conditions and lesions. Endoscopy 2016, 48, 723–730.
  13. Lv, X.; Wang, C.; Xie, Y.; Yan, Z. Diagnostic efficacy of magnifying endoscopy with narrow-band imaging for gastric neoplasms: A meta-analysis. PLoS ONE 2015, 10, e0123832.
  14. Zhou, F.; Wu, L.; Huang, M.; Jin, Q.; Qin, Y.; Chen, J. The accuracy of magnifying narrow band imaging (me-nbi) in distinguishing between cancerous and noncancerous gastric lesions: A meta-analysis. Medicine 2018, 97, e9780.
  15. Ezoe, Y.; Muto, M.; Uedo, N.; Doyama, H.; Yao, K.; Oda, I.; Kaneko, K.; Kawahara, Y.; Yokoi, C.; Sugiura, Y.; et al. Magnifying narrowband imaging is more accurate than conventional white-light imaging in diagnosis of gastric mucosal cancer. Gastroenterology 2011, 141, 2017–2025.E3.
  16. Zhang, Q.; Wang, F.; Chen, Z.Y.; Wang, Z.; Zhi, F.C.; Liu, S.D.; Bai, Y. Comparison of the diagnostic efficacy of white light endoscopy and magnifying endoscopy with narrow band imaging for early gastric cancer: A meta-analysis. Gastric Cancer Off. J. Int. Gastric Cancer Assoc. Jpn. Gastric Cancer Assoc. 2016, 19, 543–552.
  17. Hu, Y.Y.; Lian, Q.W.; Lin, Z.H.; Zhong, J.; Xue, M.; Wang, L.J. Diagnostic performance of magnifying narrow-band imaging for early gastric cancer: A meta-analysis. World J. Gastroenterol. 2015, 21, 7884–7894.
  18. Yao, K.; Doyama, H.; Gotoda, T.; Ishikawa, H.; Nagahama, T.; Yokoi, C.; Oda, I.; Machida, H.; Uchita, K.; Tabuchi, M. Diagnostic performance and limitations of magnifying narrow-band imaging in screening endoscopy of early gastric cancer: A prospective multicenter feasibility study. Gastric Cancer Off. J. Int. Gastric Cancer Assoc. Jpn. Gastric Cancer Assoc. 2014, 17, 669–679.
  19. Muto, M.; Yao, K.; Kaise, M.; Kato, M.; Uedo, N.; Yagi, K.; Tajiri, H. Magnifying endoscopy simple diagnostic algorithm for early gastric cancer (mesda-g). Dig. Endosc. 2016, 28, 379–393.
  20. Parikh, N.D.; Chaptini, L.; Njei, B.; Laine, L. Diagnosis of sessile serrated adenomas/polyps with image-enhanced endoscopy: A systematic review and meta-analysis. Endoscopy 2016, 48, 731–739.
  21. Zhang, Q.W.; Teng, L.M.; Zhang, X.T.; Zhang, J.J.; Zhou, Y.; Zhou, Z.R.; Hou, Y.C.; Ge, Z.Z.; Li, X.B. Narrow-band imaging in the diagnosis of deep submucosal colorectal cancers: A systematic review and meta-analysis. Endoscopy 2017, 49, 564–580.
  22. Li, M.; Ali, S.M.; Umm-a-OmarahGilani, S.; Liu, J.; Li, Y.Q.; Zuo, X.L. Kudo’s pit pattern classification for colorectal neoplasms: A meta-analysis. World J. Gastroenterol. 2014, 20, 12649–12656.
  23. Minoda, Y.; Ogino, H.; Chinen, T.; Ihara, E.; Haraguchi, K.; Akiho, H.; Takizawa, N.; Aso, A.; Tomita, Y.; Esaki, M.; et al. Objective validity of the japan narrow-band imaging expert team classification system for the differential diagnosis of colorectal polyps. Dig. Endosc. 2019, 31, 544–551.
  24. Sumimoto, K.; Tanaka, S.; Shigita, K.; Hirano, D.; Tamaru, Y.; Ninomiya, Y.; Asayama, N.; Hayashi, N.; Oka, S.; Arihiro, K.; et al. Clinical impact and characteristics of the narrow-band imaging magnifying endoscopic classification of colorectal tumors proposed by the japan nbi expert team. Gastrointest. Endosc. 2017, 85, 816–821.
  25. Puig, I.; Lopez-Ceron, M.; Arnau, A.; Rosinol, O.; Cuatrecasas, M.; Herreros-de-Tejada, A.; Ferrandez, A.; Serra-Burriel, M.; Nogales, O.; Vida, F.; et al. Accuracy of the narrow-band imaging international colorectal endoscopic classification system in identification of deep invasion in colorectal polyps. Gastroenterology 2019, 156, 75–87.
  26. Guo, T.J.; Chen, W.; Chen, Y.; Wu, J.C.; Wang, Y.P.; Yang, J.L. Diagnostic performance of magnifying endoscopy with narrow-band imaging in differentiating neoplastic colorectal polyps from non-neoplastic colorectal polyps: A meta-analysis. J. Gastroenterol. 2018, 53, 701–711.
  27. Backes, Y.; Moss, A.; Reitsma, J.B.; Siersema, P.D.; Moons, L.M. Narrow band imaging, magnifying chromoendoscopy, and gross morphological features for the optical diagnosis of t1 colorectal cancer and deep submucosal invasion: A systematic review and meta-analysis. Am. J. Gastroenterol. 2017, 112, 54–64.
  28. Backes, Y.; Schwartz, M.P.; Ter Borg, F.; Wolfhagen, F.H.J.; Groen, J.N.; de Vos Tot Nederveen Cappel, W.H.; van Bergeijk, J.; Geesing, J.M.J.; Spanier, B.W.M.; Didden, P.; et al. Multicentre prospective evaluation of real-time optical diagnosis of t1 colorectal cancer in large non-pedunculated colorectal polyps using narrow band imaging (the optical study). Gut 2019, 68, 271–279.
  29. Mannath, J.; Subramanian, V.; Hawkey, C.J.; Ragunath, K. Narrow band imaging for characterization of high grade dysplasia and specialized intestinal metaplasia in barrett’s esophagus: A meta-analysis. Endoscopy 2010, 42, 351–359.
  30. Qumseya, B.J.; Wang, H.; Badie, N.; Uzomba, R.N.; Parasa, S.; White, D.L.; Wolfsen, H.; Sharma, P.; Wallace, M.B. Advanced imaging technologies increase detection of dysplasia and neoplasia in patients with barrett’s esophagus: A meta-analysis and systematic review. Clin. Gastroenterol. Hepatol Off. Clin. Pract. J. Am. Gastroenterol. Assoc. 2013, 11, 1562–1570.
  31. Goda, K.; Fujisaki, J.; Ishihara, R.; Takeuchi, M.; Takahashi, A.; Takaki, Y.; Hirasawa, D.; Momma, K.; Amano, Y.; Yagi, K.; et al. Newly developed magnifying endoscopic classification of the japan esophageal society to identify superficial barrett’s esophagus-related neoplasms. Esophagus Off. J. Jpn. Esophageal Soc. 2018, 15, 153–159.
  32. Sharma, P.; Hawes, R.H.; Bansal, A.; Gupta, N.; Curvers, W.; Rastogi, A.; Singh, M.; Hall, M.; Mathur, S.C.; Wani, S.B.; et al. Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in barrett’s oesophagus: A prospective, international, randomised controlled trial. Gut 2013, 62, 15–21.
  33. Hattori, S.; Iwatate, M.; Sano, W.; Hasuike, N.; Kosaka, H.; Ikumoto, T.; Kotaka, M.; Ichiyanagi, A.; Ebisutani, C.; Hisano, Y.; et al. Narrow-band imaging observation of colorectal lesions using nice classification to avoid discarding significant lesions. World J. Gastrointest. Endosc. 2014, 6, 600–605.
  34. Rex, D.K.; Repici, A.; Gross, S.A.; Hassan, C.; Ponugoti, P.L.; Garcia, J.R.; Broadley, H.M.; Thygesen, J.C.; Sullivan, A.W.; Tippins, W.W.; et al. High-definition colonoscopy versus endocuff versus endorings versus full-spectrum endoscopy for adenoma detection at colonoscopy: A multicenter randomized trial. Gastrointest. Endosc. 2018, 88, 335–344.e2.
  35. Vleugels, J.L.A.; Koens, L.; Dijkgraaf, M.G.W.; Houwen, B.; Hazewinkel, Y.; Fockens, P.; Dekker, E. on behalf of the DISCOUNT study group. Suboptimal endoscopic cancer recognition in colorectal lesions in a national bowel screening programme. Gut 2020, 69, 977–980.
  36. Oyama, T. Stomach. In Atlas of Early Neoplasias of the Gastrointestinal Tract: Endoscopic Diagnosis and therapeutic Decisions; Berr, F., Oyama, T., Ponchon, T., Yahagi, N., Eds.; Springer: Berlin/Heidelberg, Germany, 2019; p. 318.
  37. Okubo, M.; Tahara, T.; Shibata, T.; Nakamura, M.; Yoshioka, D.; Maeda, Y.; Yonemura, J.; Ishizuka, T.; Arisawa, T.; Hirata, I. Changes in gastric mucosal patterns seen by magnifying nbi during h. Pylori eradication. J. Gastroenterol. 2011, 46, 175–182.
  38. Yoshifuku, Y.; Sanomura, Y.; Oka, S.; Kuroki, K.; Kurihara, M.; Mizumoto, T.; Urabe, Y.; Hiyama, T.; Tanaka, S.; Chayama, K. Clinical usefulness of the vs classification system using magnifying endoscopy with blue laser imaging for early gastric cancer. Gastroenterol. Res. Pract. 2017, 2017, 3649705.
  39. Wagner, A.; Zandanell, S.; Reinold, R.; Mitrakow, A.; Neureiter, D.; Klieser, E.; Kiesslich, T.; Mayr, C.; Berr, F.; Holzinger, J.; et al. Implementierung eines blended learning-konzepts (endo-blc) zur optimierung der detektion und charakterisierung von frühkarzinomen im gastrointestinaltrakt. In DGVS Digital: BEST OF DGVS; DGVS: Berlin, Germany, 2020.
  40. Dekker, E.; Houwen, B.; Puig, I.; Bustamante-Balen, M.; Coron, E.; Dobru, D.E.; Kuvaev, R.; Neumann, H.; Johnson, G.; Pimentel-Nunes, P.; et al. Curriculum for optical diagnosis training in europe: European society of gastrointestinal endoscopy (esge) position statement. Endoscopy 2020, 52, 899–923.
  41. Bisschops, R.; East, J.E.; Hassan, C.; Hazewinkel, Y.; Kaminski, M.F.; Neumann, H.; Pellise, M.; Antonelli, G.; Bustamante Balen, M.; Coron, E.; et al. Advanced imaging for detection and differentiation of colorectal neoplasia: European society of gastrointestinal endoscopy (esge) guideline—Update 2019. Endoscopy 2019, 51, 1155–1179.
Contributor :
View Times: 52
Revisions: 2 times (View History)
Update Time: 13 Jul 2021
Table of Contents


    Are you sure to Delete?

    Video Upload Options

    Do you have a full video?
    If you have any further questions, please contact Encyclopedia Editorial Office.
    Wagner, A. Diagnosis of Early Gastrointestinal Neoplasia. Encyclopedia. Available online: (accessed on 01 July 2022).
    Wagner A. Diagnosis of Early Gastrointestinal Neoplasia. Encyclopedia. Available at: Accessed July 01, 2022.
    Wagner, Andrej. "Diagnosis of Early Gastrointestinal Neoplasia," Encyclopedia, (accessed July 01, 2022).
    Wagner, A. (2021, July 13). Diagnosis of Early Gastrointestinal Neoplasia. In Encyclopedia.
    Wagner, Andrej. ''Diagnosis of Early Gastrointestinal Neoplasia.'' Encyclopedia. Web. 13 July, 2021.